SRS Capital Advisors, Inc. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
SRS Capital Advisors, Inc. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,222
+89.8%
7,275
+219.8%
0.00%
+100.0%
Q2 2023$6,439
+69.2%
2,275
+193.5%
0.00%0.0%
Q1 2023$3,806
-54.3%
7750.0%0.00%0.0%
Q4 2022$8,324
+18.9%
775
+4.0%
0.00%0.0%
Q3 2022$7,0000.0%7450.0%0.00%0.0%
Q2 2022$7,000
-22.2%
7450.0%0.00%0.0%
Q1 2022$9,0000.0%7450.0%0.00%0.0%
Q4 2021$9,000
-25.0%
7450.0%0.00%
-50.0%
Q3 2021$12,000745
+2880.0%
0.00%
Q2 2021$0250.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders